G. Tumoral pathology

• myofibroblastic fusiform cells
  21 November

  Examples
  proliferative fasciitis https://twitter.com/01sth02/status/1197195284360634370 https://twitter.com/histiocytosisX/status/726137886693806081 https://twitter.com/VishwasParekh/status/701774294997716992 https://twitter.com/feaselp811/status/733792267266330624
  See also
  fusiform cells

• fibroblastic fusiform cells
  21 November

  myofibroblastic fusiform cells
  Examples
  proliferative fasciitis https://twitter.com/01sth02/status/1197195284360634370 https://twitter.com/histiocytosisX/status/726137886693806081 https://twitter.com/VishwasParekh/status/701774294997716992 https://twitter.com/feaselp811/status/733792267266330624
  See also
  fusiform cells

• ganglion-like myofibroblasts
  21 November

  ganglion-like cells
  Examples
  proliferative fasciitis https://twitter.com/01sth02/status/1197195284360634370 https://twitter.com/histiocytosisX/status/726137886693806081 https://twitter.com/VishwasParekh/status/701774294997716992 https://twitter.com/feaselp811/status/733792267266330624

• gangliocytic paraganglioma
  16 November

  Images
  https://twitter.com/jake_bledsoe/status/1195476228830060544
  See also
  gangliocytic anomalies
  paraganglioma

• palisaded architecture
  12 November

  Images
  palisaded myofibroblastoma https://twitter.com/kriyer68/status/1129242436310425600
  See also
  myofibroblastoma

• palisaded myofibroblastoma
  12 November

  Images
  Palisaded Myofibroblastoma https://twitter.com/kriyer68/status/1129242436310425600
  See also
  palisaded architecture / palisaded myofibroblastoma
  myofibroblastoma

• ALK-rearranged histiocytosis
  11 November

  ALK-positive histiocytosis
  ALK-positive histiocytosis is a systemic histiocytic proliferation of early infancy with hepatosplenomegaly and dramatic hematological disturbances.
  The clinicopathological spectrum of ALK-positive histiocytosis is broader than originally described, and this entity is characterized by frequent presence of KIF5B-ALK gene fusion.
  It has been recommended that every unusual histiocytic proliferative disorder, especially disseminated lesions, be tested for ALK (...)

• STK11-mutated tumors
  10 November

  Pathology
  STK11 somatic mutations in STK11-mutated tumors (#10079245#): STK11-mutated pulmonary adenocarcinoma (#25695224#, #23995788#, #22460425#, #21191700#, #12097271#, #10079245#) STK11-mutated cervical adenocarcinoma (#10079245#)
  See also
  STKs / STK11
  tumors mutated genes in tumors gene-mutated tumors

• dMMR tumors
  10 November

  DNA mismatch repair deficient tumors ; MSI-H
  See also
  DNA mismatch repair
  microsatellite instability

• NTRK3-rearranged fibrosarcoma
  9 November

  NTRK3-rearranged fibrosarcomas
  NTRK fusions in malignant tumors are therapeutic targets of tyrosine kinase inhibitors. Because they occur only in a small subset of mesenchymal tumors, knowledge regarding the corresponding histology is important to effectively identify patients who could benefit from targeted therapy.
  CD34-positive fibrosarcoma of bone and soft tissue could be a good candidate for NTRK testing.
  Paywall references
  Novel NTRK3 Fusions in Fibrosarcomas of Adults. Yamazaki (...)

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | ... | 1240